3 results
Approved WMOCompleted
To study whether a novel plaster (Rapydan) is more successfull in diminishing pain/ discomfort than the usual plaster (EMLA).
Approved WMORecruiting
The aim of the study is to investigate the value of DCB treatment in the residual disease of the coronary artery after successful recanalization and stenting of the actual CTO body as compared with complete stenting in a randomized fashion.
Approved WMOPending
The aim of the study is to investigate the value of DCB treatment of single de-novo coronary artery lesions in patients with stable coronary artery disease, as compared to treatment with DES in a randomized fashion.